Cytotoxic chemotherapy for hepatocellular carcinoma.

被引:0
作者
Beuzeboc, P
机构
来源
SEMAINE DES HOPITAUX | 1996年 / 72卷 / 21-22期
关键词
liver cirrhosis; liver neoplasms; carcinoma; antineoplastic agents;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The modalities and results of systemic chemotherapy and intraarterial (IA) chemotherapy with lipiodol as the vector and, if needed, Spongel embolization are reviewed. Because of high levels of multidrug resistance, the systemic route is disappointing even when combination chemotherapy is used. Although high objective response rates have been observed with IA chemotherapy, controlled trials have not provided proof that this method improves survival. Intraarterial therapy should be considered in selected patients versus other available alternatives.
引用
收藏
页码:654 / 659
页数:6
相关论文
共 60 条
[1]  
ANDO K, 1987, Cancer Chemotherapy and Pharmacology, V19, P183
[2]  
AUDISIO RA, 1990, CANCER, V66, P228, DOI 10.1002/1097-0142(19900715)66:2<228::AID-CNCR2820660206>3.0.CO
[3]  
2-G
[4]  
BEPPU T, 1991, CANCER-AM CANCER SOC, V68, P2555, DOI 10.1002/1097-0142(19911215)68:12<2555::AID-CNCR2820681204>3.0.CO
[5]  
2-8
[6]  
BHATTACHARYA S, 1995, CANCER, V76, P2202, DOI 10.1002/1097-0142(19951201)76:11<2202::AID-CNCR2820761105>3.0.CO
[7]  
2-8
[8]   PRIMARY-TREATMENT OF HEPATOCELLULAR-CARCINOMA BY ARTERIAL CHEMOEMBOLIZATION [J].
BISMUTH, H ;
MORINO, M ;
SHERLOCK, D ;
CASTAING, D ;
MIGLIETTA, C ;
CAUQUIL, P ;
ROCHE, A .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (04) :387-394
[9]  
BRONOWICKI JP, 1994, CANCER, V74, P16, DOI 10.1002/1097-0142(19940701)74:1<16::AID-CNCR2820740105>3.0.CO
[10]  
2-V